BB
INFI

BB Biotech’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

BB Biotech’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-2,700,737
Closed -$14.2M – 31
2016
Q1 		$14.2M Hold
2,700,737
– – 0.57% 24
2015
Q4 		$21.2M Hold
2,700,737
– – 0.6% 25
2015
Q3 		$22.8M Hold
2,700,737
– – 0.72% 24
2015
Q2 		$29.6M Buy
2,700,737
+80,000
+3% +$1.03M 0.8% 24
2015
Q1 		$36.6M Buy
2,620,737
+300,000
+13% +$4.59M 1.09% 24
2014
Q4 		$39.2M Hold
2,320,737
– – 1.27% 21
2014
Q3 		$31.1M Buy
2,320,737
+815,000
+54% +$9.71M 1.27% 20
2014
Q2 		$19.2M Buy
1,505,737
+205,000
+16% +$2.14M 0.91% 21
2014
Q1 		$15.5M Hold
1,300,737
– – 0.8% 19
2013
Q4 		$18M Hold
1,300,737
– – 0.96% 18
2013
Q3 		$22.7M Buy
1,300,737
+210,909
+19% +$4.04M 1.23% 19
2013
Q2 		$17.6M Buy
+1,089,828
New +$33.7M 1.27% 15

Other funds holding INFI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return